Collectively, these findings confirm that the activation of the P2X7 receptors/pannexin-1 and the sequential NLRP3 inflammasome plays a central role in the dysregulation of the immune response during pathogenesis of diseases such as IBD (Figure 1). The gene discussed is NLRP3; the disease is inflammatory bowel disease.